Meglumine antimoniate
Meglumine antimoniate
Meglumine antimoniate (pronunciation: meh-gloo-meen an-ti-moan-ee-ate) is a pharmaceutical drug used primarily in the treatment of leishmaniasis, a disease caused by protozoan parasites of the genus Leishmania.
Etymology
The term "Meglumine antimoniate" is derived from its two main components: "Meglumine", a derivative of sorbitol, and "antimoniate", a compound containing the semi-metallic element antimony.
Usage
Meglumine antimoniate is administered via intramuscular injection and is often used in combination with other drugs to treat various forms of leishmaniasis, including cutaneous, mucocutaneous, and visceral leishmaniasis. It is also used in the treatment of other parasitic diseases.
Side Effects
Common side effects of Meglumine antimoniate include nausea, vomiting, diarrhea, and abdominal pain. More serious side effects can include pancreatitis, hepatitis, and cardiac arrhythmias.
Related Terms
External links
- Medical encyclopedia article on Meglumine antimoniate
- Wikipedia's article - Meglumine antimoniate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski